Dr. Saini is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5501 Hopkins Bayview Circle
Allergy & Asthma Center, 2nd Floor
Baltimore, MD 21224Phone+1 410-550-2300Fax+1 410-550-3256
Summary
- Dr. Sarbjit Saini is an allergist/immunologist in Baltimore, MD and is affiliated with multiple hospitals in the area, including Johns Hopkins Hospital and Johns Hopkins Bayview Medical Center. He received his medical degree from The Ohio State University College of Medicine and has been in practice 26 years.
Education & Training
- Johns Hopkins UniversityFellowship, Allergy and Immunology, 1994 - 1997
- University of MichiganResidency, Internal Medicine, 1991 - 1994
- Ohio State University College of MedicineClass of 1991
Certifications & Licensure
- FL State Medical License 2020 - Present
- MD State Medical License 1995 - 2025
- MI State Medical License 1993 - 1997
- American Board of Allergy and Immunology Allergy & Immunology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013-2014
Clinical Trials
- Effect of Anti-IgE in Chronic Urticaria Start of enrollment: 2004 Nov 01
- Omalizumab in the Treatment of Peanut Allergy Start of enrollment: 2009 Jul 01
- The Effects of Omalizumab (Anti-IgE) on the Late-phase Response to Nasal Allergen Challenge Start of enrollment: 2009 Oct 01
- Join now to see all
Publications & Presentations
PubMed
- 11 citationsAssessing basophil functional measures during monoclonal anti-IgE therapySarbjit S. Saini, Donald W. MacGlashan
Journal of Immunological Methods. 2012-09-28 - 25 citationsEffects of combination treatment with tezepelumab and allergen immunotherapy on nasal responses to allergen: A randomized controlled trial.Jonathan Corren, David Larson, Matthew C Altman, R Max Segnitz, Pedro C Avila
The Journal of Allergy and Clinical Immunology. 2023-01-01 - 27 citationsShort-Term Subcutaneous Allergy Immunotherapy and Dupilumab are Well Tolerated in Allergic Rhinitis: A Randomized Trial.Jonathan Corren, Sarbjit S. Saini, Remi Gagnon, Mark H. Moss, Gordon Sussman
Journal of Asthma and Allergy. 2021-08-16
Other
- Chronic urticaria: Clinical manifestations, diagnosis, pathogenesis, and natural historySaini S
http://www.uptodate.com/contents/chronic-urticaria-clinical-manifestations-diagnosis-pathogenesis-an
UpToDate, Wolters Kluwer Health - 2013-01-28
Press Mentions
- Novel BTK Inhibitor for Chronic Hives Wins in Phase III TrialNovember 16th, 2023
External Links
- Johns Hopkins Physicianshttp://www.hopkinsmedicine.org/sarbjit-saini
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: